Prognostic Value of Somatostatin Receptor-Derived Volumetric Parameters from a Hybrid Standardized Uptake Value Thresholding Method in Patients with 68 Ga-DOTATATE-Avid Stage IV Neuroendocrine Neoplasms: A Preliminary Study
Neuroendocrinology · 2023
DOI: 10.1159/000530771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroendocrinology, 2023. Verfasst von Zhaoting Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Receptors, Somatostatin, Organometallic Compounds, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Introduction
The ability of PET/CT imaging to delineate neuroendocrine neoplasms (NENs) and predict prognosis in affected patients is often compromised by substantial uptake heterogeneity. We hereby proposed a hybrid standardized uptake value (SUV) thresholding algorithm to extract volumetric parameters from somatostatin receptor (SSTR) PET/CT imaging and investigate their prognostic performance in patients with 68Ga-DOTATATE-avid stage IV NENs.
Methods
For 38 retrospectively enrolled patients, we used either fixed SUV thresholding of normal liver parenchyma (method A), 41% of the SUVmax for each lesion (method B), or a hybrid method (method A for liver metastases; fixed SUV threshold of normal bone for bone metastases; method B for primary tumors and other metastases) to quantify the whole-body SSTR-expressing tumor volume (SRETVwb) and total lesion SSTR expression (TLSREwb). Patient survival was also recorded and analyzed.
Results
PET/CT images revealed heterogeneous uptake of 68Ga-DOTATATE at primary and metastatic sites. Progression-free survival (PFS) and overall survival (OS) were negatively correlated with the extent of liver or bone metastases (p < 0.05), but not significantly correlated with tumor grade or 18F-FDG PET/CT positivity. By the hybrid method, PFS was significantly shorter in patients with high SRETVwb, and OS was significantly shorter in those with high SRETVwb and TLSREwb (p < 0.05). However, when derived from method A or method B, neither SRETVwb nor TLSREwb could predict patient outcomes.
Conclusion
Compared with other methods used in 68Ga-DOTATATE-avid stage IV NENs, our hybrid SUV thresholding method demonstrated robustness, with greater precision, reliability, and prognostic power.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zitieren
APA
Cheng, Z., Zou, S., Zhou, J., Song, S., Zhu, Y., Zhao, J., & Zhu, X. (2023). Prognostic Value of Somatostatin Receptor-Derived Volumetric Parameters from a Hybrid Standardized Uptake Value Thresholding Method in Patients with 68 Ga-DOTATATE-Avid Stage IV Neuroendocrine Neoplasms: A Preliminary Study. Neuroendocrinology. https://doi.org/10.1159/000530771
Vancouver
Cheng Z, Zou S, Zhou J, Song S, Zhu Y, Zhao J, et al. Prognostic Value of Somatostatin Receptor-Derived Volumetric Parameters from a Hybrid Standardized Uptake Value Thresholding Method in Patients with 68 Ga-DOTATATE-Avid Stage IV Neuroendocrine Neoplasms: A Preliminary Study. Neuroendocrinology. 2023. doi:10.1159/000530771
BibTeX
@article{Cheng2023,
author = {Cheng, Zhaoting and Zou, Sijuan and Zhou, Jianyuan and Song, Shuang and Zhu, Yuankai and Zhao, Jun and Zhu, Xiaohua},
title = {Prognostic Value of Somatostatin Receptor-Derived Volumetric Parameters from a Hybrid Standardized Uptake Value Thresholding Method in Patients with 68 Ga-DOTATATE-Avid Stage IV Neuroendocrine Neoplasms: A Preliminary Study},
journal = {Neuroendocrinology},
year = {2023},
doi = {10.1159/000530771}
}
EUVIMED